Quantcast

Latest Beta-lactam Stories

2009-09-11 10:52:53

A recently patented chemical additive could make old antibiotics effective again against resistant bacteria, a Texas Tech researcher said. A short chain of nucleic acid, called an aptamer, can stop antibiotic-resistant bacteria from breaking down antibiotics, said Robert Shaw, associate chairman of Texas Tech's Department of Chemistry. Aptamers could invigorate beta-lactam antibiotics, such as penicillins, carbapenems and cephalosporins, which account for nearly $30 billion in annual sales in...

2009-09-11 02:00:00

PARIS, September 11 /PRNewswire/ -- Novexel, a specialty pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its pipeline will be the subject of 16 posters and one slide presentation at the 49th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

2009-06-16 07:00:00

Uptake of Novel Agents from Novexel, Johnson & Johnson and Wyeth Will Drive Growth, According to a New Report from Decision Resources WALTHAM, Mass., June 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite generic erosion of key brands, the hospital-acquired gram-negative infections drug market will increase by $1 billion from 2008 to 2018 in the United States, France, Germany, Italy,...

2009-06-04 05:45:00

VIENNA, Austria, June 4 /PRNewswire/ -- EUCODIS Bioscience, a company developing enzymes for the chemical, the pharmaceutical, and other industries, announced today that it has successfully launched its first commercial enzyme, a beta-lactamase.

2009-05-18 01:30:00

PARIS, May 18 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its two most advanced pipeline products NXL104 and NXL103 are the subject of four posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

2009-04-27 15:00:00

LANSING, Mich., April 27 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has expanded its line of products developed for the worldwide dairy industry to include the quickest single test available to simultaneously detect beta-lactam and tetracycline antibiotic residues in milk. Developed to comply with the European Union's maximum residue levels, Neogen's new BetaStar(R) Combo utilizes the same format as the popular BetaStar assay -- an extremely easy lateral flow test that...

2009-03-03 01:30:00

PARIS, March 3 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today that its most advanced injectable antibacterial, which combines Novexel's broad spectrum beta lactamase inhibitor, NXL104, with the well established cephalosporin antibiotic, ceftazidime, has entered a second Phase II clinical trial. This Phase II trial with...

2009-01-09 09:05:06

Scientists at St. Jude Children's Research Hospital have demonstrated a more effective treatment for bacterial pneumonia following influenza.

2008-11-12 03:00:05

PARIS, November 12 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today that its most advanced injectable antibacterial, which combines Novexel's broad spectrum beta-lactamase inhibitor, NXL104, with the well established cephalosporin antibiotic, ceftazidime, has entered Phase II clinical trials.


Word of the Day
ponerology
  • An interdisciplinary study of social injustice.
The word 'ponerology' was coined by Andrzej Łobaczewski, a Polish psychiatrist. It comes from a Greek word meaning "evil".